
Sunbeam Biotech Limited
About Sunbeam Biotech Limited
Data last updated:
Sunbeam Biotech Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 11 March 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U01403MH2008PLC177347.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Rajesh Jain and Sunil Jasraj Chordia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sunbeam Chambers Ground Floor Opp: Liberty Cinema New Marine Lines, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹77,311. For the same year it recorded a net loss of ₹2.92 Lakh (net margin -378%) and EBITDA of -₹2.92 Lakh (EBITDA margin -378%).
Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sunbeam Biotech Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSunbeam Chambers Ground Floor Opp: Liberty Cinema New Marine Lines, Mumbai, Maharashtra, India – 400020
- IndustryReal Estate and Construction, Real Estate Builders & Developers
To see the full contact details of Sunbeam Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sunbeam Biotech Limited
FY 2025 filings availableSunbeam Biotech Limited reported revenue of ₹77,311 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -378% | ||||
| Net Profit Margin | -378% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunbeam Biotech Limited, buy the company report.
Board of directors of Sunbeam Biotech Limited
Sunbeam Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Jain | Director | 20 Apr 2013 | 13 Years 6 Months | Current |
| Sunil Jasraj Chordia Also directs: Sunrise Housing Paradise LLP, Best Deal Properties Private Limited, Mother Earth Granites LLP and 2 more | Director | 20 Apr 2013 | 13 Years 6 Months | Current |
| Balchand Harakchand Jain Also directs: Sunrise Lifespaces LLP, Sunrise Skyscrapers LLP, Sunrise Housing Paradise LLP and 5 more | Director | 04 Jan 2008 | 18 Years 10 Months | Current |
Peer comparison
Sunbeam Biotech Limited is compared with the 10 companies closest to it by revenue in the Real Estate industry (Builders and Developers), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Palace Gardens Chennai Sez Private Limited | ₹77,538 (FY 2016) | Mumbai, Maharashtra, India | ||||
| SKB Realty Private Limited | ₹77,381 (FY 2025) | 25.0% | Bhubaneswar, Odisha, India | |||
| Ajay Heights (India) Private Limited | ₹77,381 (FY 2025) | -97.0% | Bhopal, Madhya Pradesh, India | |||
| Susa Realtors Private Limited | ₹77,380 (FY 2024) | -95.0% | Mumbai, Maharashtra, India | |||
| Auspicious Infrastructure Private Limited | ₹77,364 (FY 2025) | -100.0% | New Delhi, Delhi, India | |||
| Sunbeam Biotech Limitedthis company | ₹77,311 (FY 2025) | -₹2.92 Lakh | -378% | Mumbai, Maharashtra, India | ||
| Shree Laxmi Realcon Private Limited | ₹77,311 (FY 2025) | New Delhi, Delhi, India | ||||
| Ultima Hygiene Products Private Limited | ₹77,240 (FY 2025) | 16.0% | Gurugram, Haryana, India | |||
| Trimurti Vatika Private Limited | ₹77,192 (FY 2025) | 292.0% | Kolkata, West Bengal, India | |||
| Excel Sales Private Limited | ₹77,096 (FY 2025) | Kolkata, West Bengal, India | ||||
| Katesaria Food Products Private Limited | ₹77,065 (FY 2025) | 5.0% | Dhanbad, Jharkhand, India |
To see the full peer comparison of Sunbeam Biotech Limited, buy the company report.
Auditor
Sunbeam Biotech Limited is audited by ARPIT CHOPRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARPIT CHOPRA & CO | FY 2018 | 018378C |
Shareholding
The shareholding of Sunbeam Biotech Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sunbeam Biotech Limited, buy the company report.
Legal cases
Sunbeam Biotech Limited has 5 court cases on record: 1 filed by Sunbeam Biotech, 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 0 |
Cases on record (3 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI REV APP) | Filed by the company against State and the Deputy Registrar of Companies -- Respondents | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Dy. Registrar of Companies | Disposed |
To see the full case history of Sunbeam Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunbeam Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sunbeam Biotech Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sunbeam Biotech Limited has 6 board changes on record since 2008: 3 appointments and 3 cessations. The latest: Samir Rebati Jha ceased to be Director on 23 Apr 2013.
Frequently asked questions
Sunbeam Biotech is an active public limited company based in Mumbai, Maharashtra, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 11 March 2008 (18+ years old) and is registered under CIN U01403MH2008PLC177347.
Sunbeam Biotech has 3 current directors:
- Rajesh Jain - Director
- Sunil Jasraj Chordia - Director
- Balchand Harakchand Jain - Director
The latest financial statements of Sunbeam Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sunbeam Biotech is U01403MH2008PLC177347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunbeam Biotech has 5 court cases on record: 1 filed by the company and 4 filed against it.
Sunbeam Biotech was incorporated on 11 March 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sunbeam Biotech by revenue are Palace Gardens Chennai Sez Private Limited, SKB Realty Private Limited, Ajay Heights (India) Private Limited, Susa Realtors Private Limited, Auspicious Infrastructure Private Limited and 5 more, all in the Real Estate industry (Builders and Developers).
Samir Rebati Jha ceased to be Director on 23 Apr 2013. Vishal Krishanlal Dua ceased to be Director on 23 Apr 2013. Rajesh Jain was appointed as Director on 20 Apr 2013. Sunbeam Biotech has 6 board changes on record in total.
The registered office of Sunbeam Biotech is at Sunbeam Chambers Ground Floor Opp: Liberty Cinema New Marine Lines, Mumbai, Maharashtra, India – 400020.
Sunbeam Biotech operates in the real estate and construction industry, in the real estate builders and developers segment.
The compliance status of Sunbeam Biotech is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.

